Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep;8(3):495-501.
doi: 10.1007/s13555-018-0253-2. Epub 2018 Jul 26.

Topical Application of 5-Fluorouracil Associated with Distant Seborrheic Dermatitis-like Eruption: Case Report and Review of Seborrheic Dermatitis Cutaneous Reactions after Systemic or Topical Treatment with 5-Fluorouracil

Affiliations

Topical Application of 5-Fluorouracil Associated with Distant Seborrheic Dermatitis-like Eruption: Case Report and Review of Seborrheic Dermatitis Cutaneous Reactions after Systemic or Topical Treatment with 5-Fluorouracil

Tyler Werbel et al. Dermatol Ther (Heidelb). 2018 Sep.

Abstract

Introduction: 5-Fluorouracil is a fluoropyrimidine antineoplastic medication that is used to topically treat actinic keratoses. Although local adverse effects to the drug are common and anticipated, distant skin reactions are rare and unexpected. In this case report, we describe a patient who developed seborrheic dermatitis-like eruption at a distant site after topical application of 5-fluorouracil to his arms.

Case report: A 63-year-old man with actinic keratoses on his arms developed a facial seborrheic dermatitis-like reaction after topically applying 5-fluorouracil 5% cream twice daily to actinic keratoses on his forearms for 7 days. The facial dermatosis resolved shortly after discontinuation of the 5-fluorouracil; upon rechallenge of topical 5-fluorouracil on his arms, the facial seborrheic dermatitis recurred.

Discussion: Several case reports have been published which describe exacerbations of preexisting seborrheic dermatitis with local topical 5-fluorouracil. Additionally, one case series describes the development of scrotal dermatitis in two patients after distant treatment with 5-fluorouracil. The pathogenesis that causes this distant reaction is unclear.

Conclusion: We describe a patient with a seborrheic dermatitis eruption after topical application of 5-fluorouracil at a distant site. The etiologic association between the drug and adverse effect was confirmed with multiple cycles of application and discontinuation of the offending agent.

Keywords: 5-Fluorouracil; Actinic; Dermatitis; Keratosis; Seborrheic; Topical; Toxicity.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Distant (a, b, c) and closer (d, e, f) views of the face of a 63-year-old man shows a seborrheic dermatitis-like eruption following the topical application of 5-fluorouracil on his arms
Fig. 2
Fig. 2
Front (a) and back (b) views of a 63-year-old man shows his extensor forearms after topical treatment with 5-fluorouracil. Hyperpigmentation and scaling erythematous plaques are present on the right (c) and left (d) extensor forearms, consistent with 5-fluorouracil-treated actinic keratoses, are noted

Similar articles

Cited by

References

    1. Longley DB, Harkin DP, Johnston PG. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3(5):330–338. doi: 10.1038/nrc1074. - DOI - PubMed
    1. Gupta AK, Bluhm R, Cooper EA, Summerbell RC, Batra R. Seborrheic dermatitis. Dermatol Clin. 2003;21(3):401–412. doi: 10.1016/S0733-8635(03)00028-7. - DOI - PubMed
    1. Amstutz U, Froehlich TK, Largiadèr CR. Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity. Pharmacogenomics. 2011;12(9):1321–1336. doi: 10.2217/pgs.11.72. - DOI - PubMed
    1. Meulendijks D, Henricks LM, Sonke GS, et al. Clinical relevance of DPYD variants c.1679T > G, c.1236G > A/HapB3, and c.1601G > A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data. Lancet Oncol. 2015;16(16):1639–1650. doi: 10.1016/S1470-2045(15)00286-7. - DOI - PubMed
    1. Vaitkevicius VK, Brennan MJ, Beckett VL, Kelly JE, Talley RW. Clinical evaluation of cancer chemotherapy with 5-fluorouracil. Cancer. 1961;14:131–152. doi: 10.1002/1097-0142(196101/02)14:1<131::AID-CNCR2820140118>3.0.CO;2-3. - DOI - PubMed